Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josh Wallsh

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Ophthalmology|September 22, 2023
ReplyJosh Wallsh, Pawan Bhatnagar
Ophthalmology|May 1, 2023
ReplyJosh Wallsh, Pawan Bhatnagar
Retinal Cases & Brief Reports|November 11, 2014
Optical coherence tomography difference maps and average macular volume for geographic atrophyJosh Wallsh, Ron Gallemore
Clinical Ophthalmology (Auckland, N.Z.)|June 17, 2016
Therapeutic effect of dexamethasone implant in retinal vein occlusions resistant to anti-VEGF therapyJosh Wallsh, Behnam Sharareh, Ron Gallemore
Clinical Ophthalmology (Auckland, N.Z.)|April 23, 2021
Long-Term Outcomes of Macular Hole Repair with Triamcinolone Acetonide VisualizationJosh Wallsh, Masumi G Asahi, Ron Gallemore
Clinical Ophthalmology (Auckland, N.Z.)|October 29, 2020
Initial Ten Years of Experience with the Intravitreal Dexamethasone Implant: A Retrospective Chart ReviewJosh Wallsh, Charlotte Luths, Haily Kil, et al.
Retina (Philadelphia, Pa.)|March 23, 2013
Recalcitrant macular edema after intravitreal bevacizumab is responsive to an intravitreal dexamethasone implant in retinal vein occlusionBehnam Sharareh, Ron Gallemore, Mehran Taban, et al.
Expert Opinion on Emerging Drugs|May 25, 2021
Emerging biological therapies for the treatment of age-related macular degenerationMasumi G Asahi, Jaycob Avaylon, Josh Wallsh, et al.
Clinical Ophthalmology (Auckland, N.Z.)|November 6, 2020
Multifocal ERG and Microperimetry Changes in Response to Ranibizumab Treatment of Neovascular AMD: Randomized Phase 2 Open-Label StudyMasumi G Asahi, Josh Wallsh, Spencer M Onishi, et al.
Clinical Ophthalmology (Auckland, N.Z.)|February 10, 2017
Combination verteporfin photodynamic therapy ranibizumab-dexamethasone in choroidal neovascularization due to age-related macular degeneration: results of a phase II randomized trialRon P Gallemore, Josh Wallsh, Henry L Hudson, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Ophthalmology|September 22, 2023
ReplyJosh Wallsh, Pawan Bhatnagar
Ophthalmology|May 1, 2023
ReplyJosh Wallsh, Pawan Bhatnagar
Retinal Cases & Brief Reports|November 11, 2014
Optical coherence tomography difference maps and average macular volume for geographic atrophyJosh Wallsh, Ron Gallemore
Clinical Ophthalmology (Auckland, N.Z.)|June 17, 2016
Therapeutic effect of dexamethasone implant in retinal vein occlusions resistant to anti-VEGF therapyJosh Wallsh, Behnam Sharareh, Ron Gallemore
Clinical Ophthalmology (Auckland, N.Z.)|April 23, 2021
Long-Term Outcomes of Macular Hole Repair with Triamcinolone Acetonide VisualizationJosh Wallsh, Masumi G Asahi, Ron Gallemore
Clinical Ophthalmology (Auckland, N.Z.)|October 29, 2020
Initial Ten Years of Experience with the Intravitreal Dexamethasone Implant: A Retrospective Chart ReviewJosh Wallsh, Charlotte Luths, Haily Kil, et al.
Retina (Philadelphia, Pa.)|March 23, 2013
Recalcitrant macular edema after intravitreal bevacizumab is responsive to an intravitreal dexamethasone implant in retinal vein occlusionBehnam Sharareh, Ron Gallemore, Mehran Taban, et al.
Expert Opinion on Emerging Drugs|May 25, 2021
Emerging biological therapies for the treatment of age-related macular degenerationMasumi G Asahi, Jaycob Avaylon, Josh Wallsh, et al.
Clinical Ophthalmology (Auckland, N.Z.)|November 6, 2020
Multifocal ERG and Microperimetry Changes in Response to Ranibizumab Treatment of Neovascular AMD: Randomized Phase 2 Open-Label StudyMasumi G Asahi, Josh Wallsh, Spencer M Onishi, et al.
Clinical Ophthalmology (Auckland, N.Z.)|February 10, 2017
Combination verteporfin photodynamic therapy ranibizumab-dexamethasone in choroidal neovascularization due to age-related macular degeneration: results of a phase II randomized trialRon P Gallemore, Josh Wallsh, Henry L Hudson, et al.
Pageof 1